Literature DB >> 30475264

Strain-specific effect on biphasic DNA binding by HIV-1 integrase.

Kyle J Hill1,2,3, Leonard C Rogers1,3,4, Duncan T Njenda5, Donald H Burke1,2, Stefan G Sarafianos6, Anders Sönnerborg5,7, Ujjwal Neogi5, Kamalendra Singh1,2,5.   

Abstract

: The oligomerization of HIV-1 integrase onto DNA is not well understood. Here we show that HIV-1 integrase binds the DNA in biphasic (high-affinity and low-affinity) modes. For HIV-1 subtype B, the high-affinity mode is ∼100-fold greater than the low-affinity mode (Kd.DNA = 37 and 3400 nmol/l, respectively). The Kd.DNA values of patient-derived integrases containing subtype-specific polymorphisms were affected two- to four-fold, suggesting that polymorphisms may have an influence on effective-concentrations of inhibitors, as these inhibitors preferably bind to integrase-DNA complex.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30475264      PMCID: PMC6472922          DOI: 10.1097/QAD.0000000000002078

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  31 in total

1.  Displacement of viral DNA termini from stable HIV-1 integrase nucleoprotein complexes induced by secondary DNA-binding interactions.

Authors:  I K Pemberton; H Buc; M Buckle
Journal:  Biochemistry       Date:  1998-02-24       Impact factor: 3.162

2.  Antiretroviral potency of 4'-ethnyl-2'-fluoro-2'-deoxyadenosine, tenofovir alafenamide and second-generation NNRTIs across diverse HIV-1 subtypes.

Authors:  Duncan T Njenda; Shambhu G Aralaguppe; Kamalendra Singh; Rohit Rao; Anders Sönnerborg; Stefan G Sarafianos; Ujjwal Neogi
Journal:  J Antimicrob Chemother       Date:  2018-10-01       Impact factor: 5.790

3.  Diketo acid inhibitor mechanism and HIV-1 integrase: implications for metal binding in the active site of phosphotransferase enzymes.

Authors:  Jay A Grobler; Kara Stillmock; Binghua Hu; Marc Witmer; Peter Felock; Amy S Espeseth; Abigail Wolfe; Melissa Egbertson; Michele Bourgeois; Jeffrey Melamed; John S Wai; Steve Young; Joseph Vacca; Daria J Hazuda
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-07       Impact factor: 11.205

4.  Differential effects of the G118R, H51Y, and E138K resistance substitutions in different subtypes of HIV integrase.

Authors:  Peter K Quashie; Maureen Oliviera; Tamar Veres; Nathan Osman; Ying-Shan Han; Said Hassounah; Yolanda Lie; Wei Huang; Thibault Mesplède; Mark A Wainberg
Journal:  J Virol       Date:  2014-12-31       Impact factor: 5.103

5.  Cryo-EM structures and atomic model of the HIV-1 strand transfer complex intasome.

Authors:  Dario Oliveira Passos; Min Li; Renbin Yang; Stephanie V Rebensburg; Rodolfo Ghirlando; Youngmin Jeon; Nikoloz Shkriabai; Mamuka Kvaratskhelia; Robert Craigie; Dmitry Lyumkis
Journal:  Science       Date:  2017-01-06       Impact factor: 47.728

6.  Retroviral intasome assembly and inhibition of DNA strand transfer.

Authors:  Stephen Hare; Saumya Shree Gupta; Eugene Valkov; Alan Engelman; Peter Cherepanov
Journal:  Nature       Date:  2010-01-31       Impact factor: 49.962

7.  A soluble active mutant of HIV-1 integrase: involvement of both the core and carboxyl-terminal domains in multimerization.

Authors:  T M Jenkins; A Engelman; R Ghirlando; R Craigie
Journal:  J Biol Chem       Date:  1996-03-29       Impact factor: 5.157

8.  Author Correction: Analyses of HIV-1 integrase sequences prior to South African national HIV-treatment program and availability of integrase inhibitors in Cape Town, South Africa.

Authors:  Dominik Brado; Adetayo Emmanuel Obasa; George Mondinde Ikomey; Ruben Cloete; Kamalendra Singh; Susan Engelbrecht; Ujjwal Neogi; Graeme Brendon Jacobs
Journal:  Sci Rep       Date:  2018-04-16       Impact factor: 4.379

9.  Prevalence of resistance to integrase strand-transfer inhibitors (INSTIs) among untreated HIV-1 infected patients in Morocco.

Authors:  Najwa Alaoui; Moulay Abdelaziz El Alaoui; Nadia Touil; Hicham El Annaz; Marouane Melloul; Reda Tagajdid; Naoufal Hjira; Mohamed Boui; El Mostapha El Fahime; Saad Mrani
Journal:  BMC Res Notes       Date:  2018-06-08

10.  The M50I polymorphic substitution in association with the R263K mutation in HIV-1 subtype B integrase increases drug resistance but does not restore viral replicative fitness.

Authors:  Melissa Wares; Thibault Mesplède; Peter K Quashie; Nathan Osman; Yingshan Han; Mark A Wainberg
Journal:  Retrovirology       Date:  2014-01-17       Impact factor: 4.602

View more
  5 in total

1.  Novel Naturally Occurring Dipeptides and Single-Stranded Oligonucleotide Act as Entry Inhibitors and Exhibit a Strong Synergistic Anti-HIV-1 Profile.

Authors:  Rafael Ceña-Diez; Kamalendra Singh; Anna-Lena Spetz; Anders Sönnerborg
Journal:  Infect Dis Ther       Date:  2022-04-07

Review 2.  Long-Acting Anti-HIV Drugs Targeting HIV-1 Reverse Transcriptase and Integrase.

Authors:  Kamal Singh; Stefan G Sarafianos; Anders Sönnerborg
Journal:  Pharmaceuticals (Basel)       Date:  2019-04-20

3.  Extended Interactions between HIV-1 Viral RNA and tRNALys3 Are Important to Maintain Viral RNA Integrity.

Authors:  Thomas Gremminger; Zhenwei Song; Juan Ji; Avery Foster; Kexin Weng; Xiao Heng
Journal:  Int J Mol Sci       Date:  2020-12-23       Impact factor: 5.923

4.  Genetic Features of HIV-1 Integrase Sub-Subtype A6 Predominant in Russia and Predicted Susceptibility to INSTIs.

Authors:  Alina Kirichenko; Ilya Lapovok; Pavel Baryshev; David A M C van de Vijver; Jeroen J A van Kampen; Charles A B Boucher; Dimitrios Paraskevis; Dmitry Kireev
Journal:  Viruses       Date:  2020-07-31       Impact factor: 5.048

5.  Short Communication: Integrase Strand Transfer Inhibitors Drug Resistance Mutations in Puerto Rico HIV-Positive Individuals.

Authors:  Pablo López; Grissell Tirado; Andrea Arias; Raphael Sánchez; Elliott R Rodríguez-López; Vanessa Rivera-Amill
Journal:  Int J Environ Res Public Health       Date:  2021-03-08       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.